Should a QP audit CROs and Investigators?
Recommendation
18-20 November 2025
Heidelberg, Germany
GMP and FDA Compliance in Pharmaceutical Development and IMP Manufacturing
Register now for ECA's GMP Newsletter
As third set in row of Q&A documents, the European QP Association has published a Q&A document on IMP-related questions.
The new set of questions (on the European QP Association website) is dealing with topics like:
- Completeness of the IMPD
- Reanalysis of IMPs
- Audits
- Contracts
Related GMP News
17.09.2025WHO Guidelines on Reducing Animal Testing
08.09.2025Latest Information on the EMA's Clinical Trials Information System (CTIS)
27.08.20253R - A Global Approach with Implications for the Pharmaceutical Industry
17.07.2025ICH E20 Draft Guideline on Adaptive Design for Clinical Trials
17.07.2025Update on ICH Guidelines E21 & E22